ArticleCell biology and toxicology2026
Mechanisms of TRIM21-mediated RUNX2 degradation via chaperone-mediated autophagy in periodontitis.
Article in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The osteogenic capability of periodontal ligament cells in periodontitis is impaired partly due to decreased RUNX2 expression. Mass spectrometry identified TRIM21 as a protein that interacts with RUNX2 and facilitates its degradation. Pharmacological inhibition experiments revealed that blocking the lysosomal pathway significantly attenuated TRIM21-mediated RUNX2 degradation, whereas inhibition of the proteasome or macroautophagy had no such effect. Subsequent analysis revealed that the KFERQ-like motif in TRIM21 is crucial for its identification in chaperone-mediated autophagy (CMA). TRIM21 mutants lacking this motif failed to bind the chaperone protein HSC70 and could not mediate RUNX2 degradation. HSC70 identifies the KFERQ motif in TRIM21, aiding the transport of the TRIM21-RUNX2 complex to lysosomal-associated membrane protein 2A (LAMP2A) on the lysosome surface, which promotes RUNX2 degradation. In conclusion, our study demonstrated that TRIM21 mediated RUNX2 degradation through the lysosome-mediated CMA, driven by its interaction with HSC70 via the KFERQ motif. This mechanism is exacerbated in periodontitis due to elevated TRIM21 expression, leading to reduced RUNX2 levels. These findings provide new insights into the impaired osteogenic capacity in periodontitis and highlight TRIM21 as a potential therapeutic target to restore RUNX2 function and enhance bone regeneration in periodontal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.